Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
BPC-157 (a 15-amino-acid gastric peptide derivative) and TB-500 (the 17–23 fragment of thymosin beta-4) both demonstrate antifibrotic effects in MASH models, but their upstream mechanisms diverge completely. BPC-157 binds to VEGF…
Copper Peptides (GHK-Cu) Upregulates lysyl oxidase for collagen cross-linking; removes perifollicular fibrosis Topical solution 1–2% concentration applied daily 6–12 months +3–5% hair density, no significant change in follicle co…
The most overlooked variable in peptides for frailty research compared across labs isn't the peptide itself. It's preparation consistency. Lyophilised peptides must be reconstituted with bacteriostatic water at the correct concen…
The table below directly compares the three peptides for frailty research most commonly evaluated in preclinical and clinical frailty studies. BPC-157 VEGF upregulation, angiogenesis Vascular endothelium, connective tissue Improv…
Telogen effluvium doesn't respond to the same interventions as androgenetic aloppia because the underlying pathology is fundamentally different. In androgenetic alopecia, follicles miniaturize progressively over years due to chro…
Kisspeptin-54 (full-length) GPR54 (KISS1R) <30 minutes Poor (requires ICV) Modeling pulsatile GnRH secretion and HPG axis restoration Gold standard for upstream hormonal models but impractical for sustained-release or peripheral …
CJC-1295 with Drug Affinity Complex (DAC) is a synthetic GHRH analog engineered with a maleimide-linked albumin-binding moiety. This modification extends its plasma half-life from 7 minutes (native GHRH) to approximately 6–8 days…
The distinction between acute neuroprotection (preventing secondary injury cascade) and long-term functional recovery (promoting synaptic reorganization and neurogenesis) is where most peptides for TBI research compared diverge s…
PT-141 (bremelanotide) is a cyclic heptapeptide that functions as a melanocortin receptor agonist. Specifically targeting MC3R and MC4R in the hypothalamus and spinal cord. Unlike PDE5 inhibitors (sildenafil, tadalafil), which re…
Semax (N-acetyl-Semax) BDNF upregulation, MAO modulation, circadian entrainment signaling Strengthens SCN-peripheral clock synchronization, increases monoamine availability during circadian low points 60–90 minutes (intranasal) 6…
The confusion around peptides for torn rotator cuff healing stems from conflating 'supports healing' with 'accelerates recovery'. These are not synonymous. TB-500 supports healing by ensuring adequate angiogenesis occurs, but if …
The table below compares the three most studied peptides for Crohn's disease research based on primary mechanism, optimal research application, typical dosing ranges in animal models, and key outcome measures that demonstrate mec…
CJC-1295 DAC GHRH receptor agonist (pituitary) 6–8 days Sustained GH pulsatility restoration IGF-1 elevation, lean mass gain, bone density Best for anabolic signaling studies; requires weekly dosing to avoid receptor desensitisat…
BPC-157 NF-κB inhibition, angiogenesis Reduces stellate cell activation and fibrosis 250–500 mcg SC daily Preclinical (animal models) Thymosin Beta-4 Actin polymerization, anti-apoptotic Promotes hepatocyte regeneration 2–5 mg SC…
GLP-1 Agonist (Semaglutide 2.4mg) GLP-1 receptor only 33–40% relative reduction 59% (vs 17% placebo) No significant change at 72 weeks Proven NASH resolution. Fibrosis benefit requires longer observation GIP/GLP-1 Dual Agonist (T…
GHRP-2 Ghrelin receptor agonist ~20–30 minutes 100–300mcg 2–3x daily High (4–6x baseline) 1.8–2.7x at 8–12 weeks Transient hunger, mild water retention Most potent acute GH response; preserves pulsatility Ipamorelin Selective ghr…
This table compares the three primary peptides used in clinical CIRS protocols, their mechanisms, dosing, and application timing. Thymosin Alpha-1 Modulates T-cell differentiation; reduces IL-6, TNF-alpha 0.9–1.6mg subcutaneous, …
DSIP (Delta Sleep-Inducing Peptide) GABA-B sensitization, delta-opioid modulation Increases slow-wave sleep by 20–30%, preserves REM 15–30 minutes Small-batch synthesis required for sequence fidelity MK 677 (Ibutamoren) Ghrelin r…
Mast Cell Stabilisers (e.g., KPV) Inhibits NF-κB translocation, prevents degranulation MRGPRX2 receptor modulation, calcium channel regulation Reduces spontaneous histamine release, brain fog, flushing Preclinical models, in vitr…
Before selecting a research peptide, compare mechanism specificity, evidence quality, and biological risk profile across candidates. Thymalin Thymic regeneration → naive T-cell expansion with longer baseline telomeres Moderate (R…